ConductScience.org, home

Trial · NCT03467425

Adverse events258

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherDyspnoeaRespiratory, thoracic and mediastinal disordersFF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI321,54532
otherDyspnoeaRespiratory, thoracic and mediastinal disordersNon-Ellipta MITT31,5473
seriousPneumoniaInfections and infestationsFF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI261,54527
seriousPneumoniaInfections and infestationsNon-Ellipta MITT301,54730
seriousChronic obstructive pulmonary diseaseRespiratory, thoracic and mediastinal disordersFF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI261,54528
seriousChronic obstructive pulmonary diseaseRespiratory, thoracic and mediastinal disordersNon-Ellipta MITT281,54729
seriousInfective exacerbation of chronic obstructive airways diseaseInfections and infestationsFF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI61,5456
seriousInfective exacerbation of chronic obstructive airways diseaseInfections and infestationsNon-Ellipta MITT91,5479
seriousAcute myocardial infarctionCardiac disordersFF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI51,5455
seriousAcute myocardial infarctionCardiac disordersNon-Ellipta MITT51,5475
seriousCardiac failureCardiac disordersFF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI31,5453
seriousCardiac failureCardiac disordersNon-Ellipta MITT71,5477
seriousAtrial fibrillationCardiac disordersFF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI41,5454
seriousAtrial fibrillationCardiac disordersNon-Ellipta MITT51,5475
seriousMyocardial infarctionCardiac disordersFF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI51,5455
seriousMyocardial infarctionCardiac disordersNon-Ellipta MITT21,5472
seriousFallInjury, poisoning and procedural complicationsFF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI21,5452
seriousFallInjury, poisoning and procedural complicationsNon-Ellipta MITT31,5473
seriousSepsisInfections and infestationsFF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI31,5453
seriousSepsisInfections and infestationsNon-Ellipta MITT21,5472

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03467425/events